Abstract
The integration of GammaPod™ technology at the IRCCS Fondazione Pascale in Naples represents an innovative breakthrough in the field of ultraselective breast radiotherapy (S-PBI). Designed for early-stage breast cancer, the device uses 25 rotating Cobalt-60 (60Co) sources with very high dose gradient collimation. The present study analyzes the clinical and organizational impact of the equipment, focusing on the operational workflow of the Medical Radiology Technician (TSRM), the sizing and selection phases of the vacuum Breast Cup, organ dosimetry and the strategic positioning of the institute in the international scientific panorama. The prone approach and vacuum immobilization cancel respiratory movements, ensuring sub-millimeter precision. The dose to the heart (average <0.5 Gy) and ipsilateral lung (V20Gy < 1.5%) is significantly reduced compared to conventional LINACs. The integrated workflow reduces the overall duration of treatment and skin exposure. The adoption of the system standardizes the operating practice by eliminating skin tattoos and positions IRCCS Pascale as a reference Hub in Southern Europe and an active member of the International Clinical Consortium

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Gennaro Gentile
